Abstract
As genomic sequencing becomes more widely available in clinical settings for diagnostic purposes, a number of genetic counseling issues are gaining precedence. The ability to manage these issues will be paramount as genetic and non-genetic healthcare professionals navigate the complexities of using genomic technologies to facilitate diagnosis and inform patient management. Counseling issues arising when counseling for diagnostic genomic sequencing were identified by four genetic counselors with 10 years of collective experience providing genetic counseling in this setting. These issues were discussed and refined at a meeting of genetic counselors working in clinical genomics settings in Melbourne, Australia. Emerging counseling issues, or variations of established counseling issues, were identified from the issues raised. Illustrative cases were selected where pre- and post-test genetic counseling was provided in clinical settings to individuals who received singleton or trio WES with targeted analysis. Counseling issues discussed in this paper include a reappraisal of how genetic counselors manage hope in the genomic era, informed consent for secondary use of genomic data, clinical reanalysis of genomic data, unexpected or unsolicited secondary findings, and trio sequencing. The authors seek to contribute to the evolving understanding of genetic counseling for diagnostic genomic sequencing through considering the applicability of existing genetic counseling competencies to managing emerging counseling issues and discussing genetic counseling practice implications.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Accreditation Council for Genetic Counseling. (2015). Practice-based competencies for genetic counselors. Retrieved from www.gceducation.org website: 1st August 2017.
ACMG Board of Directors. (2012). Points to consider in the clinical application of genomic sequencing. Genetics in Medicine, 14(8), 759–761. https://doi.org/10.1038/gim.2012.74
Amendola, L. M., Lautenbach, D., Scollon, S., Bernhardt, B., Biswas, S., East, K., et al. (2015). Illustrative case studies in the return of exome and genome sequencing results. Personalized Medicine, 12(3), 283–295. https://doi.org/10.2217/pme.14.89
Arora, S., Haverfield, E., Richard, G., Haga, S. B., & Mills, R. (2016). Clinical and counseling experiences of early adopters of whole exome sequencing. Journal of Genetic Counseling, 25(2), 337–343. https://doi.org/10.1007/s10897-015-9876-y
Austin, J., Semaka, A., & Hadjipavlou, G. (2014). Conceptualizing genetic counseling as psychotherapy in the era of genomic medicine. Journal of Genetic Counseling, 23(6), 903–909. https://doi.org/10.1007/s10897-014-9728-1
Biesecker, B. B., & Peters, K. F. (2001). Process studies in genetic counseling: peering into the black box. American Journal of Medical Genetics, 106(3), 191–198. https://doi.org/10.1002/ajmg.10004
Borders, L. D., Eubanks, S., & Callanan, N. (2006). Supervision of psychosocial skills in genetic counseling. Journal of Genetic Counseling, 15(4), 211–223. https://doi.org/10.1007/s10897-006-9024-9
Donchin, A. (2000). Autonomy, interdependence, and assisted suicide: respecting boundaries/crossing lines. Bioethics, 14(3), 187–204. https://doi.org/10.1111/1467-8519.00190
Elias, S., & Annas, G. J. (1994). Generic consent for genetic screening. New England Journal of Medicine, 330(22), 1611–1613. https://doi.org/10.1056/nejm199406023302213
Facio, F. M., Lee, K., & O’Daniel, J. M. (2014). A genetic counselor’s guide to using next-generation sequencing in clinical practice. Journal of Genetic Counseling, 23(4), 455–462. https://doi.org/10.1007/s10897-013-9662-7
Fanos, J. H. (2012). New “first families”: the psychosocial impact of new genetic technologies. Genetics in Medicine, 14(2), 189–190. https://doi.org/10.1038/gim.2011.17
Gaff, C. L., Winship, M. I., Forrest, M. S., Hansen, P., Clark, D. J., Waring, M. P., et al. (2017). Preparing for genomic medicine: a real world demonstration of health system change. npj Genomic Medicine, 2(16), 1–9. https://doi.org/10.1038/s41525-017-0017-4
Grove, M. E., Wolpert, M. N., Cho, M. K., Lee, S. S.-J., & Ormond, K. E. (2014). Views of genetics health professionals on the return of genomic results. Journal of Genetic Counseling, 23(4), 531–538. https://doi.org/10.1007/s10897-013-9611-5
Hooker, G. W., Ormond, K. E., Sweet, K., & Biesecker, B. B. (2014). Teaching genomic counseling: preparing the genetic counseling workforce for the genomic era. Journal of Genetic Counseling, 23(4), 445–451. https://doi.org/10.1007/s10897-014-9689-4
Human Genetics Society of Australasia. (2016). Guidelines for training and certification in genetic counselling. p11–15. Retrieved from www.hgsa.org.au website: 1st August 2017.
Knoppers, B. M., & Chadwick, R. (2005). Human genetic research: emerging trends in ethics. Nature Reviews Genetics, 6(1), 75–79. https://doi.org/10.1038/nrg1505
Korner, I. N. (1970). Hope as a method of coping. Journal of Consulting and Clinical Psychology, 34(2), 134–139. https://doi.org/10.1037/h0029004
Krabbenborg, L., Schieving, J., Kleefstra, T., Vissers, L. E. L. M., Willemsen, M. A., Veltman, J. A., & van der Burg, S. (2016a). Evaluating a counseling strategy for diagnostic WES in paediatric neurology: an exploration of parents’ information and communication needs. Clinical Genetics, 89(2), 244–250. https://doi.org/10.1111/cge.12601
Krabbenborg, L., Vissers, L. E. L. M., Schieving, J., Kleefstra, T., Kamsteeg, E. J., Veltman, J. A., et al. (2016b). Understanding the psychosocial effects of WES test results on parents of children with rare diseases. Journal of Genetic Counseling, 25(6), 1207–1214. https://doi.org/10.1007/s10897-016-9958-5
Machini, K., Douglas, J., Braxton, A., Tsipis, J., & Kramer, K. (2014). Genetic counselors’ views and experiences with the clinical integration of genome sequencing. Journal of Genetic Counseling, 23(4), 496–505. https://doi.org/10.1007/s10897-014-9709-4
Mills, R., & Haga, S. B. (2014). Genomic counseling: next generation counseling. Journal of Genetic Counseling, 23(4), 689–692. https://doi.org/10.1007/s10897-013-9641-z
Ormond, K. E. (2013). From genetic counseling to “genomic counseling”. Molecular Genetics & Genomic Medicine, 1(4), 189–193. https://doi.org/10.1002/mgg3.45
Ormond, K. E., Wheeler, M. T., Hudgins, L., Klein, T. E., Butte, A. J., Altman, R. B., et al. (2010). Challenges in the clinical application of whole-genome sequencing. The Lancet, 375(9727), 1749–1751. https://doi.org/10.1016/S0140-6736(10)60599-5
Resta, R., Biesecker, B. B., Bennett, R. L., Blum, S., Estabrooks Hahn, S., Strecker, M. N., & Williams, J. L. (2006). A new definition of genetic counseling: National Society of Genetic Counselors’ task force report. Journal of Genetic Counseling, 15(2), 77–83. https://doi.org/10.1007/s10897-005-9014-3
Roche, M. I., & Palmer, C. G. S. (2014). Next generation genetic counseling: introduction to the special issue. Journal of Genetic Counseling, 23(4), 439–444. https://doi.org/10.1007/s10897-014-9729-0
Ropers, H.-H. (2012). On the future of genetic risk assessment. Journal of Community Genetics, 3(3), 229–236. https://doi.org/10.1007/s12687-012-0092-2
Rothwell, E., Johnson, E., Mathiesen, A., Golden, K., Metcalf, A., Rose, N. C., & Botkin, J. R. (2017). Experiences among women with positive prenatal expanded carrier screening results. Journal of Genetic Counseling, 26(4), 690–696. https://doi.org/10.1007/s10897-016-0037-8
Sadedin, S. P., Dashnow, H., James, P. A., Bahlo, M., Bauer, D. C., Lonie, A., et al. (2015). Cpipe: a shared variant detection pipeline designed for diagnostic settings. Genome Medicine, 7(1), 68. https://doi.org/10.1186/s13073-015-0191-x
Sapp, J. C., Dong, D., Stark, C., Ivey, L. E., Hooker, G., Biesecker, L. G., & Biesecker, B. B. (2014). Parental attitudes, values, and beliefs toward the return of results from exome sequencing in children. Clinical Genetics, 85(2), 120–126. https://doi.org/10.1111/cge.12254
Stark, Z., Tan, T. Y., Chong, B., Brett, G. R., Yap, P., Walsh, M., et al. (2016). A prospective evaluation of whole-exome sequencing as a first-tier molecular test in infants with suspected monogenic disorders. Genetics in Medicine, 18(11), 1090–1096. https://doi.org/10.1038/gim.2016.1
Tabor, H. K., Stock, J., Brazg, T., McMillin, M. J., Dent, K. M., Yu, J.-H., et al. (2012). Informed consent for whole genome sequencing: a qualitative analysis of participant expectations and perceptions of risks, benefits, and harms. American Journal of Medical Genetics Part A, 158A(6), 1310–1319. https://doi.org/10.1002/ajmg.a.35328
Tan, T. Y., Dillon, O., Stark, Z., Schofield, D., Alam, K., Shrestha, R., ... White, S. M. (2017). Diagnostic impact and cost-effectiveness of whole-exome sequencing for ambulant children with suspected monogenic conditions. JAMA Pediatrics, Published online July 31, 2017. doi: https://doi.org/10.1001/jamapediatrics.2017.1755.
Tolusso, L. K., Collins, K., Zhang, X., Holle, J. R., Valencia, C. A., & Myers, M. F. (2017). Pediatric whole exome sequencing: an assessment of parents’ perceived and actual understanding. Journal of Genetic Counseling, 26(4), 792–805. https://doi.org/10.1007/s10897-016-0052-9
Weil, J. (2002). Genetic counselling in the era of genomic medicine: as we move towards personalised medicine, it becomes more important to help patients understand genetic tests and make complex decisions about their health. EMBO Reports, 3(7), 590–593. https://doi.org/10.1093/embo-reports/kvf144
Wicklund, C., & Trepanier, A. (2014). Adapting genetic counseling training to the genomic era: more an evolution than a revolution. Journal of Genetic Counseling, 23(4), 452–454. https://doi.org/10.1007/s10897-014-9690-y
Wilkins, E. J., Archibald, A. D., Sahhar, M. A., & White, S. M. (2016). “It wasn’t a disaster or anything”: Parents’ experiences of their child’s uncertain chromosomal microarray result. American Journal of Medical Genetics Part A, 170(11), 2895–2904. https://doi.org/10.1002/ajmg.a.37838
Winship, I., & Southey, M. C. (2016). Gene panel testing for hereditary breast cancer. The Medical Journal of Australia, 204(5), 188–190. https://doi.org/10.5694/mja15.01335
Wynn, J. (2016). Genomic testing: a genetic counselor’s personal reflection on three years of consenting and testing. Journal of Genetic Counseling, 25(4), 691–697. https://doi.org/10.1007/s10897-015-9868-y
Acknowledgements
The authors thank the participants for their involvement and thank Associate Professor Clara Gaff for guidance in the preparation of this manuscript. The authors are funded by the Melbourne Genomics Health Alliance and the State Government of Victoria (Department of Health and Human Services).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of Interest
Gemma R Brett, Ella J Wilkins, Emma T Creed, Kirsty West, Anna Jarmolowicz, Giulia M Valente, Yael Prawer, Elly Lynch, and Ivan Macciocca declare they have no conflict of interest.
Human Studies and Informed Consent
All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1975, as revised in 2000 (5). Informed consent was obtained from all patients for being included in the study.
Animal Studies
No animal studies were carried out by the authors for this article.
Rights and permissions
About this article
Cite this article
Brett, G.R., Wilkins, E.J., Creed, E.T. et al. Genetic Counseling in the Era of Genomics: What’s all the Fuss about?. J Genet Counsel 27, 1010–1021 (2018). https://doi.org/10.1007/s10897-018-0216-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10897-018-0216-x